Final-Program-ATS-2023-AP.vp

WEDNESDAY • MAY 24

319

1113 Eloesser Flap - An Innovative Option to Treat Broncho-Pleural Fistula/ A. Sinha Ray, Omaha, NE 1114 Gastric Mucormycosis in a Liver Transplant Patient Presenting With Perforation and Pleural Extension/ S. Mayer, Lone Tree, CO 1115 Sealing the Leak: A Novel Multidisciplinary Approach to Non-surgical Management of Pancreaticobronchial Fistula/ M. Lucki, Los Angeles, CA 1116 Pancreatopleural Fistula With Massive Pleural Effusion: A Case Report/ J. Rose, Dallas, TX 1117 Four-year Follow-up of a Case of Yellow Nail Syndrome With IgM Deficiency/ S. Nagpal, Johnson, TN 1118 High Low Chylo: A Case Demonstrating the Use of Lipoprotein Electrophoresis to Diagnose Chylothorax Following Endoscopic Sleeve Gastrectomy/ F. Plastikwala, Charlottesville, VA 1119 Chylothorax After Thoracic Radiation Therapy/ J. Rowell, Burlington, VT 1120 Malignant Myelomatous Pleural Effusion: An Indicator Of Poor Prognosis/ D. Rongo, Dallas, TX 1121 A Rare Cause Of Bilateral Pleural Effusions/ B. Reuland, New York, NY 1122 Which Drug Is It? Valproic Acid Mediated Eosinophilic Pleural Effusion in a Patient on Multiple Anti-epileptics/ K.Z. Abbas, Cleveland, OH 1123 Colchicine For Pleuritic Chest Pain Secondary to Pulmonary Infarction Caused by Pulmonary Embolism/ R. Rani, Washington, DC

102 Characteristics and Mortality of Patients With Septic Cardiomyopathy Compared to Those With Septic Shock/ M.M. Cirulis, Salt Lake City, UT 103 Validation of Lung Ultrasound to Predict Respiratory Failure Among Hospitalized Adults With Sepsis/ E. Ponce, Miami, FL 104 Unsupervised Classification of Host Response Biomarkers Reveals HIV-driven Prognostic Subgroups Among Adults With Malaria-associated Sepsis in Uganda/ P. Seekaew, New York, NY 105 Time-series Machine Learning Approach to Sepsis Prediction in the Intensive Care Unit/ I. Sears, Providence, RI 106 Thiamine for Renal Protection in Septic Shock: A Randomized Trial/ A. Moskowitz, Bronx, NY 107 Physician-Level Variation in Steroid Prescribing Practices in Septic Shock: A Retrospective Cohort Study Using a Multi-Hospital Electronic Health Record/ J.S. Minturn, Pittsburgh, PA 108 Distinct Neutrophil Phenotypes in Sepsis Patients and Associations With Clinical Outcomes and Sources of Sepsis/ S. Pettigrew, Philadelphia, PA 109 Use of Phenylephrine Compared to Norepinephrine in Patients With Sepsis; a Meta-analysis of Mortality and Review of Current Literature/ Y. Ishisaka, New York, NY 110 In Septic Patients, Early Treatment With Anti-anaerobic Antibiotics Increases 90-day Mortality in an Instrumental Variable Analysis/ R. Chanderraj, Ann Arbor, MI 111 A Retrospective Cohort Study Assessing Respiratory Outcomes in Patients With Sepsis Secondary to Pneumonia Who Achieved >=30 CC/KG Fluid Goals/ H.J. Young, Fairborn, OH 112 Diagnostic Utility of Urinary Glycosaminoglycan Levels in Septic Shock Patients: Secondary Analysis of Fluid Responsiveness Evaluation in Sepsis Hypotension and Shock (FRESH) Trial/ A. Longino, Aurora, CO 113 Insurance Status and Illness Severity on Emergency Department Presentation Among Patients With Community-acquired Sepsis/ A. Bowman, Salt Lake City, UT 114 Disseminated Intravascular Coagulation (DIC) in Septic Shock Patients: An Analysis of Disparities in Patient Demographics and In-hospital Outcomes/ K. Shankar, Darby, PA 115 Understanding Practice Variation When the Evidence Is Uncertain: A Longitudinal Survey of Critical Care Providers Steroid Use in Septic Shock/ K. Soni, Pittsburgh, PA 116 Hospital-based Sepsis Policies for Early Recognition and Treatment: A Multi-hospital Survey in Michigan/ M.K. Loser, Ann Arbor, MI

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

D25

TOPICS IN SEPSIS AND SEPTIC SHOCK

8:00 a.m. - 10:00 a.m.

Marriott Marquis Washington Marquis Ballroom, Salons 1-2 (Level M2)

Poster Viewing

8:00-8:45 8:45-10:00

Discussion

Chairing: M.P. Kerlin, MD, MS, Philadelphia, PA M.C. Ferrera, MD, Boston, MA S. Bhavani, MD, Atlanta, GA 101 The Presence of Malignancy Modifies the Association Between Inflammatory Phenotype and Mortality in a Prospective Study of Critically Ill Septic Patients/ L. Ronner, Philadelphia, PA

ATS 2023 • Washington, DC